title: Treatment of the elderly patient with mantle cell lymphoma.
abstract: Treatment options for mantle cell lymphomas have expanded considerably over recent years, offering hematologists solutions for older patients with an appropriate risk-to-benefit ratio. Indeed, unfit older patients are exposed to a higher risk of toxicity with a standard treatment. Although new treatments have generally good safety profiles, they may lead to unexpected consequences in unfit older patients. Involving geriatricians and a comprehensive geriatric assessment in patient care could help hematologists address these vulnerabilities. The geriatric evaluation process is time-consuming but can be simplified, and its potential to help hematologists foresee unexpected consequences of treatment has now been demonstrated.
authors.affiliation: Department of Medical Oncology, Institut Bergonié, Bordeaux, France; and.
authors.forename: Pierre
authors.initials: P
authors.lastname: Soubeyran
authors.affiliation: Department of Hematology, Centre Hospitalier Universitaire Grenoble, La Tronche, France.
authors.forename: Rémy
authors.initials: R
authors.lastname: Gressin
mesh_terms: D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D006299:Health Services for the Aged; D006801:Humans; D020522:Lymphoma, Mantle-Cell / Q000188:drug therapy*